Literature DB >> 9458623

Pregnancy, persistent microchimerism, and autoimmune disease.

J L Nelson1.   

Abstract

Fetal cells have been detected in maternal peripheral blood in the majority of normal pregnancies, and the influx of fetal cells into the maternal circulation increases during parturition. Recently, fetal progenitor cells have been found to persist in maternal peripheral blood for decades after childbirth--which has potential implications for some autoimmune diseases in women, such as scleroderma. Scleroderma has a strong female predominance, a steep increase in incidence in women following the childbearing years, and clinical similarity to the chronic graft-versus-host disease that occurs after allogenic bone marrow transplantation. This article explores the hypothesis that microchimerism (nonhost cells) contributes to the pathogenesis of scleroderma and certain other autoimmune disorders.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9458623

Source DB:  PubMed          Journal:  J Am Med Womens Assoc (1972)        ISSN: 0098-8421


  4 in total

1.  Tissue chimerism in systemic lupus erythematosus is related to injury.

Authors:  Idske C L Kremer Hovinga; Marije Koopmans; Hans J Baelde; Emile de Heer; Jan A Bruijn; Ingeborg M Bajema
Journal:  Ann Rheum Dis       Date:  2007-06-21       Impact factor: 19.103

2.  Peripartum cardiomyopathy: the need for a national database.

Authors:  S I Lok; J H Kirkels; C Klöpping; P A F Doevendans; N de Jonge
Journal:  Neth Heart J       Date:  2011-01-27       Impact factor: 2.380

Review 3.  Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia.

Authors:  Nandor Gabor Than; Roberto Romero; Andrea Balogh; Eva Karpati; Salvatore Andrea Mastrolia; Orna Staretz-Chacham; Sinuhe Hahn; Offer Erez; Zoltan Papp; Chong Jai Kim
Journal:  J Pathol Transl Med       Date:  2015-05-15

Review 4.  Peripartum cardiomyopathy: review of the literature.

Authors:  Pradipta Bhakta; Binay K Biswas; Basudeb Banerjee
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.